Edgewood Oncology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $20M

  • Investors
  • 2

Edgewood Oncology General Information

Description

Developer of a molecule designed for patients with hematologic malignancies. The company creates a novel small molecule, multi-kinase inhibitor that synergistically co-targets master regulators of cancer to activate programmed cell death, or apoptosis, enabling doctors to treat patients with genetically-defined solid tumors.

Contact Information

Website
www.edgewoodoncology.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 207 Washington Street
  • P.O. Box 471012
  • Brookline, MA 02447
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 207 Washington Street
  • P.O. Box 471012
  • Brookline, MA 02447
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edgewood Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 25-Mar-2024 $20M Completed Clinical Trials - Phase 2
1. Accelerator/Incubator Completed Stealth
To view Edgewood Oncology’s complete valuation and funding history, request access »

Edgewood Oncology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed
To view Edgewood Oncology’s complete cap table history, request access »

Edgewood Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecule designed for patients with hematologic malignancies. The company creates a novel small molecule,
Drug Discovery
Brookline, MA
2 As of 2025

Santa Monica, CA
 

Dallas, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edgewood Oncology Competitors (95)

One of Edgewood Oncology’s 95 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA
Instil Bio Formerly VC-backed Dallas, TX
Bolden Therapeutics Venture Capital-Backed Providence, RI
Immix Biopharma Formerly VC-backed Los Angeles, CA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 95 competitors. Get the full list »

Edgewood Oncology Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Edgewood Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025199434-A1 Methods of treating breast cancer using a pyrazole compound Pending 21-Mar-2024
WO-2025199440-A1 Methods of treating liposarcoma using a pyrazole compound Pending 21-Mar-2024
US-20240417479-A1 Anti-il 18bp antibodies Active 06-Jan-2023
US-12365737-B2 Anti-il-18bp antibodies Active 06-Jan-2023 C07K16/2866

Edgewood Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edgewood Oncology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Partners Venture Capital Minority
Yissum Accelerator/Incubator
To view Edgewood Oncology’s complete investors history, request access »

Ready to get started?

Request a free trial

Edgewood Oncology FAQs

  • When was Edgewood Oncology founded?

    Edgewood Oncology was founded in 2022.

  • Where is Edgewood Oncology headquartered?

    Edgewood Oncology is headquartered in Brookline, MA.

  • What is the size of Edgewood Oncology?

    Edgewood Oncology has 2 total employees.

  • What industry is Edgewood Oncology in?

    Edgewood Oncology’s primary industry is Drug Discovery.

  • Is Edgewood Oncology a private or public company?

    Edgewood Oncology is a Private company.

  • What is the current valuation of Edgewood Oncology?

    The current valuation of Edgewood Oncology is .

  • What is Edgewood Oncology’s current revenue?

    The current revenue for Edgewood Oncology is .

  • How much funding has Edgewood Oncology raised over time?

    Edgewood Oncology has raised $20M.

  • Who are Edgewood Oncology’s investors?

    Alta Partners and Yissum have invested in Edgewood Oncology.

  • Who are Edgewood Oncology’s competitors?

    Kite Pharma, Instil Bio, Bolden Therapeutics, Immix Biopharma, and Allogene Therapeutics are some of the 95 competitors of Edgewood Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process